Michael Morneau Net Worth & Insider Trades
Michael Morneau - VP, Viking Therapeutics, Inc
What is Michael Morneau's Net Worth?
The current estimated net worth of Viking Therapeutics, Inc's VP, Michael Morneau, is estimated to be about $1.26M . Michael Morneau owns about 94,035 units of Viking Therapeutics, Inc common stock. In the last 6 years at Viking Therapeutics, Inc, Michael Morneau has sold an estimated value of $311.96K worth.
What is Michael Morneau's Past Insider Trading?
Michael Morneau's largest sale order was 21,551 units , worth over $199.35K on May 31, 2018. In total, Michael Morneau has made about 19 transactions over 6 years of their time at Viking Therapeutics, Inc. Michael Morneau usually trades in January, with the busiest year in 2019 and 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Michael Morneau
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Michael Morneau's' Mailing Address?
- Mailing address is C/o Trius Therapeutics, Inc. 6410 Nancy Ridge Drive, Suite 101 San Diego CA 92121 CA
Viking Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Brian Lian, Ph.D. | 2020 | $577,000 | $301,000 | $2,485,102 | $1,824,346 | - | $5,187,448 |
| Brian Lian, Ph.D. | 2019 | $525,000 | $210,000 | $1,530,379 | $1,246,740 | - | $3,512,119 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1607678/000156459021018175/vktx-def14a_20210520.htm
What are Viking Therapeutics, Inc's Past Insider Trades?
Viking Therapeutics, Inc's most recent insider trade came on May 18, 2023 by Charles Rowland Jr who sold 40,000 units worth $1M . In the last 8 years, insiders at Viking Therapeutics, Inc have sold an estimated value of $37.43M and bought an estimated value of $6.67M worth of shares. Insider trading is most common in January, with the busiest year in 2023. The most active traders at the company are Brian Lian, President & CEO, Michael Morneau, VP, and Matthew Foehr, Director .
Viking Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||